基于纳米标签的侧流免疫分析在滥用药物即时检测中的研究进展OA
Advances in Nanoparticle-based Lateral Flow Immunoassay for Point-of-Care Detection of Abuse Drugs
麻精药和抗生素等药物的滥用已成为威胁全球公共卫生安全和社会稳定的重大隐患,开发快速、高效、便携且适用于资源有限场景的现场筛查技术,对实现滥用药物的早期发现、有效监管和流行趋势监测具有重要意义.侧流免疫分析(Lateral flow immunoassay,LFIA)技术凭借其操作简便、检测快速、成本低廉及适用于非实验室环境等优势,已成为滥用药物现场即时检测(Point-of-care testing,POCT)的重要技术平台.其中,纳米标签作为信号载体,通过偶联抗体输出检测信号,是LFIA实现高性能检测的关键要素.本文从LFIA技术概述出发,系统综述了其在滥用药物检测中的识别机制、纳米标签构建及信号读取模式的研究进展,并探讨了该技术当前面临的挑战及未来的发展趋势.
The abuse of drugs,including narcotics and psychotropic substances,antibiotics,and additives,has become a significant threat to global public health security and social stability.Therefore,the development of rapid,efficient,portable,and on-site screening technologies suitable for resource-limited environments is of great importance for the early detection,effective regulation,and monitoring of trends in drug abuse.Lateral flow immunoassay(LFIA),leveraging its operational simplicity,rapid response,cost-effectiveness,and suitability for non-laboratory settings,has emerged as a pivotal platform for point-of-care testing(POCT)of abuse drugs.Among these,nanotags,serving as signal carriers,play a key role in enabling high-performance LFIA by conjugating antibodies to output detection signals.This review began with a brief introduction to LFIA technology,systematically summarized recent research progress in LFIA recognition mechanisms,novel nanolabels,and signal transduction strategies for drug abuse detection,and discussed the remaining challenges and future trends in this field.
李岩杰;加德拉·塔拉甫;张宗程;布麦丽娅·热合木江;李敏;孙健
新疆医科大学药学院,新疆生物药械重点实验室,药物研究所,乌鲁木齐 830017新疆医科大学药学院,新疆生物药械重点实验室,药物研究所,乌鲁木齐 830017新疆医科大学药学院,新疆生物药械重点实验室,药物研究所,乌鲁木齐 830017新疆医科大学药学院,新疆生物药械重点实验室,药物研究所,乌鲁木齐 830017新疆医科大学药学院,新疆生物药械重点实验室,药物研究所,乌鲁木齐 830017||新疆警察学院,乌鲁木齐 830011新疆医科大学药学院,新疆生物药械重点实验室,药物研究所,乌鲁木齐 830017
侧流免疫分析滥用药物纳米标签信号读取与分析评述
Lateral flow immunoassayDrugs abuseNanolabelSignal readout and analysisReview
《分析化学》 2026 (4)
614-623,10
国家自然科学基金项目(No.82504731)、新疆医科大学高层次人才启动项目和国家级科研创新人才培育项目(No.XYD2024GR03)资助. Supported by the National Natural Science Foundation of China(No.82504731),the High-level Talents Start-up Project of Xinjiang Medical University,and the National Research Innovation Talents Cultivation Project(No.XYD2024GR03).
评论